追逐LDL胆固醇到底部 - 视角中的PCSK9
Peter Libby1, Lale Tokgözoğlu2
1Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. plibby@bwh.harvard.edu.
Nature cardiovascular research
|August 28, 2024
概括
降低低密度脂蛋白胆固醇 (LDL-C) 有效地预防动脉样硬化. 新的proprotein转化酶亚素/kexin类型9 (PCSK9) 疗法显著降低了LDL-C,改善了心血管结果.
科学领域:
- 心血管医学 心血管医学
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 低密度脂蛋白 (LDL) 是动脉样硬化的一个因果因素,这是一个主要的全球健康问题.
- 治疗降低LDL胆固醇 (LDL-C) 显著降低了心血管疾病的负担.
- 自体主导型高胆固醇血清症研究确定了蛋白转化酶亚素/素9型 (PCSK9) 作为关键的遗传驱动因素.
研究的目的:
- 审查降低LDL-C治疗对动脉样硬化事件的影响.
- 突出PCSK9在开发新型LDL-C降低策略中的重要性.
- 讨论推动心血管疾病预防进步的合作努力.
主要方法:
- 审查有关LDL-C,动脉样硬化和治疗干预措施的现有文献.
- 分析PCSK9在脂质代谢和心血管风险中的作用.
- 检查PCSK9向剂的发展和影响.
主要成果:
- 治疗干预有效降低LDL-C并改善心血管结果.
- 抑制PCSK9代表了显著的进步,使得前所未有的LDL-C降低.
- 新型PCSK9药物已在减轻心血管风险方面表现出显著的有效性.
结论:
- 针对PCSK9的治疗方法的开发标志着心血管医学的重大成功.
- 基础科学,工业和临床研究之间的成功伙伴关系对于进步至关重要.
- 持续的合作有望在打击心血管疾病方面取得进一步进展.
相关概念视频
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
596
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
596
Cholesterol: Significance and Regulation
520
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
520
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
499
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
499
Dipeptidyl Peptidase 4 Inhibitors
178
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
178
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
147
Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
147
Lipids: Dietary Sources and Requirements
708
Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ...
708


